Oral amiodarone reduces risk of arrhythmia following cardiac surgery
Pippa Murdie
This article has no abstract so we have provided the first paragraph of the full text.
Atrial tachyarrhythmia, the most frequent complication following cardiac surgery, is associated with adverse outcomes, prolonged hospitalization, and increased costs. The PAPABEAR trial, which investigated the effects of amiodarone in this setting, reports that a 13-day perioperative course of this drug reduces atrial tachyarrhythmias effectively after cardiac surgery.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Mathematical physics Added dimensions to grain growthNature News and Views (26 Apr 2007)
